A Langerhans cell is a specialized antigen-presenting cell found principally in the epidermis, the outer epithelial layer of the skin, and in certain mucosal epithelia. It captures and processes foreign and tissue-derived material and can present antigens to T cells, contributing both to immune defense and to tolerance of harmless substances. Langerhans cells have the antigen-presenting functions associated with dendritic cells, but their developmental origins and capacity for local self-renewal also resemble those of tissue-resident macrophages.
Discovery and terminology
Paul Langerhans described these cells in human skin in 1868 using gold chloride staining. Their branching appearance initially suggested a relationship to nerves. Their identity as immune cells was established through later ultrastructural, immunological, and functional studies.
Langerhans cells are distinct from the islets of Langerhans, the hormone-producing cell clusters of the pancreas, which are also named after Paul Langerhans.
Distribution and structure
In normal skin, Langerhans cells form a dispersed network, chiefly within the suprabasal epidermis. Their long cytoplasmic projections extend between keratinocytes, allowing contact with a broad area of the epithelial environment. Related populations occur in some stratified squamous mucosal epithelia, including parts of the oral and genital mucosa.
Important identifying features include:
- CD1a: a cell-surface antigen-presenting molecule involved in presenting lipid antigens.
- Langerin, or CD207: a carbohydrate-binding receptor involved in antigen uptake.
- MHC class II molecules: components of the major histocompatibility complex that support antigen presentation to CD4 T cells.
- Birbeck granules: distinctive intracellular membrane structures associated with langerin.
Birbeck granules appear rod-shaped or, when one end is expanded, “tennis-racket” shaped under electron microscopy. Langerin promotes their formation. Their presence is a classic ultrastructural feature, although contemporary identification commonly relies on marker staining rather than electron microscopy.
No single marker is sufficient in every setting. Some dendritic cells outside the epidermis also express langerin, so tissue location, morphology, and combinations of markers are important for distinguishing populations.
Development and maintenance
Much of the detailed evidence about Langerhans-cell development comes from lineage-tracing experiments in mice. These studies show that the epidermal population is established before birth from embryonic myeloid precursors, with contributions from yolk-sac-derived precursors and fetal liver monocytes.
Under steady-state conditions, resident Langerhans cells can maintain their population through local cell division, without requiring continuous replacement by circulating precursors. This distinguishes them from many conventional dendritic-cell populations.
After substantial tissue injury or inflammation, blood-derived precursors can enter the skin and contribute to replenishment. The relative contribution of resident cells and recruited precursors depends on the nature and severity of the disturbance.
The epidermal environment helps maintain Langerhans-cell identity and survival. Signals involving transforming growth factor beta and interleukin-34 are particularly important. Although many features are shared across mammals, developmental findings from experimental animals should not automatically be treated as identical in humans.
Antigen capture and migration
Langerhans cells take up extracellular material through receptor-mediated internalization and other uptake mechanisms, including phagocytosis. Captured material is processed, and peptide fragments can be displayed on MHC molecules. CD1a provides a separate pathway for presenting lipid antigens.
During activation, Langerhans cells can alter their antigen-processing machinery, increase expression of molecules involved in T-cell costimulation, and change their migratory behavior. Some leave the epidermis, pass through the dermis, and enter lymphatic vessels. Expression of the chemokine receptor CCR7 supports their migration toward draining lymph nodes, where they can interact with T cells.
This process links events at an epithelial surface to adaptive immunity. Nevertheless, Langerhans cells are not the only cells that transport skin antigens or initiate immune responses: other skin dendritic-cell populations have distinct and overlapping roles.
Immune defense and tolerance
Langerhans cells participate in responses to microorganisms and environmental antigens, but they do not simply function as triggers of inflammation. Their effects depend on the antigen, local cytokine signals, tissue condition, and interactions with other immune cells.
In some settings, they support T-cell activation and protective responses. In others, they contribute to immune tolerance, including responses involving regulatory T cells. These regulatory functions help limit unnecessary responses to self-derived material and harmless environmental exposures.
Experimental studies of allergic contact reactions illustrate this context dependence. Depending on the model and experimental conditions, Langerhans cells can promote, restrain, or be dispensable for particular responses. Findings that assign them a single universal role in skin allergy therefore oversimplify their biology.
Clinical significance
Langerhans cell histiocytosis
Langerhans cell histiocytosis is a clonal myeloid neoplasm whose abnormal cells express markers associated with Langerhans cells, notably CD1a and langerin. It may involve one organ or multiple organ systems, including bone, skin, lungs, and the pituitary region.
Many cases contain activating alterations in the MAPK signaling pathway, including BRAF alterations. Despite its name and marker profile, the disease should not be understood simply as an accumulation of otherwise normal epidermal Langerhans cells; its cellular origins involve the myeloid lineage and can differ with disease context.
Identification in tissue
Immunohistochemistry for CD1a and langerin is widely used to identify Langerhans cells and related lesional cells. S100 protein is also often expressed, but it is less specific. Interpretation depends on cellular appearance, anatomical distribution, and the broader pathological findings, rather than marker positivity alone.
Research methods and limitations
Langerhans cells are studied using tissue microscopy, flow cytometry, cell-culture systems, lineage tracing, and single-cell RNA sequencing. These approaches reveal differences between resting, migrating, inflammatory, and disease-associated populations.
Important methodological limitations include differences between human and mouse skin, changes induced by removing cells from their epithelial environment, and overlap in markers with other dendritic cells. Experiments that remove langerin-expressing cells may affect more than epidermal Langerhans cells, making it necessary to distinguish the effects of different cell populations.